BiotechTube
Home/Vyne Therapeutics/Roderick Wong, M.D.
RW

Roderick Wong, M.D.

Managing Partner, RTW Investments (Expected Exec. Chairman)

Vyne Therapeutics

Therapeutic Areas

DermatologyAutoimmuneEndocrinology

Vyne Therapeutics Pipeline

DrugIndicationPhase
VYN201Non-segmental VitiligoPhase 1b
VYN202Undisclosed Systemic Inflammatory DiseasesPreclinical
YB-101 (GS-098)Graves' Disease & Thyroid Eye DiseasePhase 1b/2b (Planned)

Leadership Team at Vyne Therapeutics

DD
David Domzalski
President & Chief Executive Officer
TZ
Tyler Zeronda
Chief Financial Officer
AS
Andrew Sklawer
Chief Operating Officer
IS
Iain Stuart
Chief Scientific Officer
JH
Jason Hoitt
Expected CEO of Combined Company (CEO of Yarrow)
View full Vyne Therapeutics profile